• PROTEOMICS AND GENOMICS

    from the same FFPE tissue

    learn more
  • MOLECULAR ANALYSIS THAT MAXIMIZES

    multiplex results from minimal tissue

    learn more
  • PATENTED LIQUID TISSUE TECHNOLOGY

    prepares both DNA & protein

    learn more

Absolute quantitation/quantification of biomarkers and identification of Genomic Mutation in Solid Tumors

At OncoPlex Diagnostics, we know physicians must have access to laboratory diagnostics that support management choices for each cancer patient. The accurate classification of a tumor by a clinical laboratory can mean improved quality of life for patients.

Quantitation of proteins from FFPE tissue samples is available only from OncoPlex Diagnostics. Building on the power of patented Liquid Tissue technology, NGS-enabled genetic analysis is also now available, giving oncologists access to the a comprehensive characterization of biomarkers within a patient's tumor. In this way, our tests provide a tumor classification, enabling physicians to apply appropriate patient management strategies and potentially improve the quality of life for patients. OncoPlex Diagnostics is a growing, CLIA-certified and CAP-certified laboratory dedicated to meeting the cancer diagnostic needs of pathologists and medical and surgical oncologists across the United States.